Poehling Capital Management’s Adient ADNT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q2
Sell
-48,256
Closed -$438K 109
2020
Q1
$438K Sell
48,256
-5,180
-10% -$104K 0.32% 65
2019
Q4
$1.14M Sell
53,436
-1,250
-2% -$27.7K 0.74% 43
2019
Q3
$1.26M Sell
54,686
-4,676
-8% -$107K 0.92% 39
2019
Q2
$1.44M Sell
59,362
-22,944
-28% -$472K 0.97% 37
2019
Q1
$1.07M Buy
82,306
+61,405
+294% +$1.08M 0.78% 49
2018
Q4
$315K Sell
20,901
-10,359
-33% -$268K 0.3% 75
2018
Q3
$1.23M Buy
31,260
+5,508
+21% +$248K 0.87% 40
2018
Q2
$1.27M Sell
25,752
-5,553
-18% -$315K 1.11% 31
2018
Q1
$1.87M Buy
31,305
+9,340
+43% +$623K 1.51% 26
2017
Q4
$1.73M Buy
+21,965
New +$1.77M 1.47% 23

Other funds holding ADNT

Poehling Capital Management's ADNT Position: Q2 2020 in Review

Poehling Capital Management sold out of Adient (ADNT) in Q2 2020, closing a stake of 48,256 shares — an estimated $438K sold.

Poehling Capital Management first reported a position in ADNT in Q4 2017 and held it in 10 quarters. The position peaked at $1.87M in Q1 2018. 284 funds tracked by Wall St. Rank hold ADNT as of Q2 2020.

  • Poehling Capital Management reported no remaining Adient position as of Q2 2020 after selling out during the quarter.
  • Poehling Capital Management sold 48,256 Adient shares in Q2 2020, an estimated $438K.
  • Poehling Capital Management first reported a position in Adient in Q4 2017 and held it in 10 quarters.
  • Poehling Capital Management's Adient position peaked at $1.87M in Q1 2018.
  • 284 funds tracked by Wall St. Rank held Adient as of Q2 2020.

Based on Poehling Capital Management's 13F filing for Q2 2020, filed 13 Aug 2020.